As it has been previously described that ID1 can modulate the expression of cyclin-dependent kinase inhibitors (CDKNs) in HepG2 cells [29], we investigated the effect of BMP13 on CDKN1A (p21) and CDKN2A (p16) expression in HCC cells. Here, ID1 is linked to hepatocellular carcinoma.